In vivo studies of the long-term /sup 51/Cr red cell survival of serologically incompatible red cell units
Journal Article
·
· Transfusion (Philadelphia); (United States)
OSTI ID:5653828
The long-term survival of serologically incompatible red cell units was measured in five patients with antibodies to high-frequency antigens. Initially, the survival of 1 ml of /sup 51/Cr-labeled incompatible red cells was measured over 1 hour. After demonstrating that the 1-hour survival times were successful (greater than 70%), each patient then received 5 ml of the same /sup 51/Cr-labeled red cells followed by the transfusion of the remainder of the red cell unit. The long-term T 1/2Cr survival for each case was patient 1 (anti-McCa), 15 days; patient 2 (anti-JMH), 12 days; patient 3 (anti-Kna), 31 days; patient 4 (anti-McCa), 12 days; and patient 5 (anti-Hya), 14 days. Each antibody tested in an in vitro homologous macrophage assay showed less than 5 percent phagocytosis. Anti-JMH was the only antibody to react with IgG subclass antisera and was determined to be IgG4. The macrophage assay, IgG subclass testing, and short-term (1 hour, 1 ml) /sup 51/Cr survival studies all indicated that the short-term survival was good. However, only the measurement of long-term survival with transfused units of serologically incompatible red cells was able to determine the actual survival, and clinical significance of the alloantibodies. Determining the actual long-term survival by the method described here can be of importance for patients requiring chronic red cell transfusion.
- Research Organization:
- Johns Hopkins Medical Institutions, Baltimore, MD
- OSTI ID:
- 5653828
- Journal Information:
- Transfusion (Philadelphia); (United States), Journal Name: Transfusion (Philadelphia); (United States) Vol. 25:1; ISSN TRANA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Long-term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW
A clinically significant erythrocyte antibody detectable only by /sup 51/Cr survival studies
Clinical significance of anti-Yt(b). Report of a case using a 51-chromium red cell survival study
Journal Article
·
· Transfusion (Philadelphia); (United States)
·
OSTI ID:5726643
A clinically significant erythrocyte antibody detectable only by /sup 51/Cr survival studies
Journal Article
·
· Transfusion (Philadelphia); (United States)
·
OSTI ID:5898695
Clinical significance of anti-Yt(b). Report of a case using a 51-chromium red cell survival study
Journal Article
·
Sun May 01 00:00:00 EDT 1988
· Transfusion (Philadelphia); (United States)
·
OSTI ID:7025594
Related Subjects
551001* -- Physiological Systems-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
ANIMAL CELLS
ANTIGEN-ANTIBODY REACTIONS
BETA DECAY RADIOISOTOPES
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BLOOD GROUPS
BODY FLUIDS
CHROMIUM 51
CHROMIUM ISOTOPES
CONNECTIVE TISSUE CELLS
ELECTRON CAPTURE RADIOISOTOPES
ERYTHROCYTES
EVEN-ODD NUCLEI
IN VIVO
INTERMEDIATE MASS NUCLEI
ISOTOPE APPLICATIONS
ISOTOPES
LABELLED COMPOUNDS
MACROPHAGES
MATERIALS
NUCLEI
PATIENTS
PHAGOCYTES
PHAGOCYTOSIS
RADIOISOTOPES
SOMATIC CELLS
SURVIVAL TIME
THERAPY
TRACER TECHNIQUES
TRANSFUSIONS
59 BASIC BIOLOGICAL SCIENCES
ANIMAL CELLS
ANTIGEN-ANTIBODY REACTIONS
BETA DECAY RADIOISOTOPES
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BLOOD GROUPS
BODY FLUIDS
CHROMIUM 51
CHROMIUM ISOTOPES
CONNECTIVE TISSUE CELLS
ELECTRON CAPTURE RADIOISOTOPES
ERYTHROCYTES
EVEN-ODD NUCLEI
IN VIVO
INTERMEDIATE MASS NUCLEI
ISOTOPE APPLICATIONS
ISOTOPES
LABELLED COMPOUNDS
MACROPHAGES
MATERIALS
NUCLEI
PATIENTS
PHAGOCYTES
PHAGOCYTOSIS
RADIOISOTOPES
SOMATIC CELLS
SURVIVAL TIME
THERAPY
TRACER TECHNIQUES
TRANSFUSIONS